Deal of the Week: The Dawn of Artificial Intelligence - Impakter

On this edition of Deal of the Week, Impakter examines startups leveraging this powerful, and controversial, technology to make the world a better place. Based in Chicago, this startup utilizes Artificial Intelligence to allow doctors to interpret and harness their patient's data to augment the precision of cancer treatment. Tempus provides genomic sequencing services and allows patient analysis at a molecular level. In general terms, the tools provided by the company allow doctors to see if there have been similar patients and what treatment had been applied in those cases. This enables doctors to understand how to treat non-standard cases of cancer.